Abstract
Prognostic assessment is crucial for the management of AML. Although the use of karyotype analysis for risk-stratification is widely accepted, prognosis of AML remains ambiguous, particularly for patients categorized into the intermediate cytogenetic risk group and additional markers are required for an accurate prediction of outcome. For this study, we used multiplex real-time RT-PCR, which can simultaneously quantify WT1 and 10 distinct fusion gene transcripts, to prospectively evaluate the pre-treatment bone marrow findings of 53 de novo AML patients. Five patients with normal karyotype or insufficient metaphases detected by conventional karyotype analysis proved to have AML1-MTG8, CBFbeta-MYH11 or PML-RARalpha fusion transcripts. WT1 overexpression was observed in 92% of the patients, and the levels were significantly higher in the cytogenetic favorable risk group, especially patients with PML-RARalpha. WT1 levels also correlated with the percentage of blasts in bone marrow, especially in cases of core-binding factor leukemia. There was no association between initial WT1 levels and outcome in terms of event-free survival or overall survival. These results suggest that multiplex real-time RT-PCR is rapid and useful for the p...Continue Reading
References
Feb 9, 1990·Cell·K M CallW H Lewis
Oct 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
May 1, 1997·Leukemia·D SchmidA Gaiger
Dec 9, 1998·Leukemia·A GaigerU Jäger
Feb 2, 2000·Bone Marrow Transplantation·A H ElmaagacliU W Schaefer
Feb 17, 2000·Nature·A A AlizadehL M Staudt
Mar 4, 2000·Nature Genetics·U ScherfJ N Weinstein
Apr 11, 2001·The EMBO Journal·L W EllisenD A Haber
Aug 25, 2001·Blood·D GrimwadeUNKNOWN Medical Research Council Adult Leukemia Working Party
Sep 6, 2001·Blood·P D KottaridisD C Linch
Jun 19, 2002·Blood·Susanne SchnittgerWolfgang Hiddemann
Jul 3, 2002·Leukemia·J TrkaUNKNOWN For Czech Paediatric Haematology Working Group
Oct 3, 2002·Leukemia·D CilloniG Saglio
Oct 24, 2002·Blood·Stefan FröhlingUNKNOWN AML Study Group Ulm. Acute myeloid leukemia
Oct 31, 2002·Blood·Hiroyasu OgawaHaruo Sugiyama
Mar 5, 2003·Leukemia & Lymphoma·Kazuoki OsumiTomoki Naoe
Sep 27, 2003·British Journal of Haematology·Mamta GargJohn A Liu Yin
Citations
Jan 29, 2011·Annals of Hematology·Alexandar TzankovUrsula Günthert
Apr 9, 2010·International Journal of Hematology·Yuho NajimaHisashi Sakamaki
Dec 26, 2006·International Journal of Hematology·Hiroya TamakiHiroyasu Ogawa
Oct 9, 2009·Leukemia & Lymphoma·Alicja Nowakowska-KoperaAleksander B Skotnicki
Oct 30, 2012·Cancer Genetics·Akihiro AbeNobuhiko Emi
Apr 9, 2005·European Journal of Haematology·Masamitsu YanadaTomoki Naoe
Dec 18, 2007·European Journal of Haematology·Mauri M HämäläinenTarja-Terttu Pelliniemi
Aug 21, 2013·Pediatric Blood & Cancer·Phoenix A HoSoheil Meshinchi
Dec 17, 2009·Hematological Oncology·Carolyn OwenPeter Paschka
Feb 12, 2013·Hematology·Ghada I MossallamHossam K Mahmoud
Apr 7, 2015·Leukemia Research·Dao-Yu ZhangXiao-Ping Chen
Jan 13, 2015·Annals of Hematology·Yang Yi-NingQin You-wen
May 21, 2011·Blood·Veronika RockovaPeter J M Valk
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter PaschkaClara D Bloomfield
Aug 3, 2006·Pediatric Blood & Cancer·Patricia C RodriguesJosé A Yunes
Jan 21, 2011·Nature Reviews. Cancer·Vicki Huff
May 26, 2007·Expert Reviews in Molecular Medicine·Suzie Ariyaratana, David M Loeb
Aug 26, 2006·Blood·Jochen GreinerLars Bullinger
Jan 27, 2019·Journal of Clinical Medicine·Ghazala Naz KhanBarbara-Ann Guinn
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jochen GreinerMichael Schmitt